2 February 2023
SHARE NOW
ATW
Automation & Digitisation
Cell Therapy
Gene Therapy
Logistics
In this Tech Demo, James Kusena, Vice President of Bioprocessing and Applications at MicrofluidX, tells us about their core technology, The Cyto Engine, as seen at Advanced Therapies Week 2023.
The Cyto Engine addresses the difficulties of translating, manufacturing and commercialising cell therapies in a cost effective manner.
James explains how this technology has demonstrated to offer superior process efficiency, repeatability and cell health.
This demo has been produced in partnership with MicrofluidX.
 |
 |
More like this
Cell and Gene Therapies News Round-Up: October 11
Welcome to Phacilitate’s weekly news round-up, which will bring you the latest advanced therapies news and resources each Friday in the lead up to Advanced Therapies Week 2025 in Dallas. This round-up covers manufacturing, investment, therapeutic development, clinical trials, and any stories making the headlines that week.
11 October 2024
